Neurovascular Devices/Interventional Neurology Market Size to Report by 2027
The global Neurovascular Devices/Interventional Neurology market gathered revenue around USD 1.8 Billion in 2020 and market is set to grow USD 5.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 9.3% during the prediction period 2021 to 2027.
Growth Factors:
The growing target patient population, ongoing product development, and commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across the emerging markets, growth in market demand for effective neurovascular devices, increase in research in the field of neurovascular therapies, rise in demand for minimally invasive neurosurgical procedures, and increase in awareness among neurosurgeons about minimally invasive surgical procedures are high growth prospects for the neurovascular devices/ interventional neurology market during the forecast period.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Neurovascular Devices/Interventional Neurology market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Neurovascular Devices/Interventional Neurology market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
| Report Scope | Details |
| Market Size | USD 5.2 Billion by 2027 |
| Growth Rate | CAGR of 9.3% From 2021 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2021 to 2027 |
| Historic Data | 2017 to 2020 |
| Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
| Segments Covered | Product, Disease pathology, End User, And Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | Johnson & Johnson , Medtronic PLC , Stryker Corporation , Terumo Corporation , Penumbra, Inc. , MicroPort Scientific Corporation , Kaneka Corp. , Integer Holdings Corporation, BALT , Perflow Medical, Phenox GmbH , Sensome, Evasc , Rapid Medical , Asahi Intecc Co. Ltd , Acandis GmbH , Medikit Co. Ltd , Imperative Care , Lepu Medical , and Cerus Endovascular , among others. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Neurovascular Devices/Interventional Neurology market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America is expected to be the largest market during the forecast period.
North America is estimated to be the largest market for neurovascular devices/interventional neurology during the forecast period. The neurovascular devices/interventional neurology market in North America is driven primarily by factors such as the growing target patient population for neurovascular diseases, rising awareness among neurosurgeons regarding the benefits offered by interventional neurology devices, and ongoing government initiatives to modernize & expand healthcare infrastructure. Additionally, the adoption of these devices has increased due to falling product prices, thereby further supporting the market growth in this region.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Neurovascular Devices/Interventional Neurology Market are: Johnson & Johnson , Medtronic PLC , Stryker Corporation , Terumo Corporation , Penumbra, Inc. , MicroPort Scientific Corporation , Kaneka Corp. , Integer Holdings Corporation, BALT , Perflow Medical, Phenox GmbH , Sensome, Evasc , Rapid Medical , Asahi Intecc Co. Ltd , Acandis GmbH , Medikit Co. Ltd , Imperative Care , Lepu Medical , and Cerus Endovascular , among others.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Based on the Technology:
Based on Disease Pathology:
Based on End Users:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Neurovascular Devices/Interventional Neurology Market, Based on the Technology
7.1. Neurovascular Devices/Interventional Neurology Market, Based on the Technology, 2021-2027
7.1.1. Aneurysm coiling & embolization devices
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Cerebral balloon angioplasty & Stenting systems
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Support devices
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Neurothrombectomy devices
7.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Neurovascular Devices/Interventional Neurology Market, Based on Disease Pathology
8.1. Neurovascular Devices/Interventional Neurology Market, Based on Disease Pathology, 2021-2027
8.1.1. Ischemic Strokes
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Cerebral Aneuryms
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Carotid Artery Stenosis
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Arteriovenous Malformations and Fistulas
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Other Diseases
8.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Neurovascular Devices/Interventional Neurology Market, Based on End Users
9.1. Neurovascular Devices/Interventional Neurology Market, Based on End Users, 2021-2027
9.1.1. Hospitals & surgical centers
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Ambulatory care centers
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Research laboratories & academic institutes
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Neurovascular Devices/Interventional Neurology Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.1.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.1.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.1.4.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.1.4.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.1.5.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.1.5.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.2.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.2.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.2.4.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.2.4.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.2.5.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.2.5.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.2.6.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.2.6.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.2.7.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.2.7.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.3.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.3.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.3.4.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.3.4.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.3.5.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.3.5.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.3.6.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.3.6.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.3.7.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.3.7.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.4.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.4.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.4.4.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.4.4.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.4.5.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.4.5.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.4.6.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.4.6.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.4.7.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.4.7.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.5.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.5.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.5.4.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.5.4.3. Market Revenue and Forecast, Based on End Users (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, Based on the Technology (2016-2027)
10.5.5.2. Market Revenue and Forecast, Based on Disease Pathology (2016-2027)
10.5.5.3. Market Revenue and Forecast, Based on End Users (2016-2027)
Chapter 11. Company Profiles
11.1. Johnson & Johnson (US)
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Medtronic PLC (Ireland)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Stryker Corporation (US)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Terumo Corporation (Japan)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Penumbra, Inc. (US)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. MicroPort Scientific Corporation (China)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Kaneka Corp. (Japan)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Integer Holdings Corporation, BALT (France)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Perflow Medical
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Phenox GmbH (Germany)
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Sensome (France)
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Evasc (Canada)
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Rapid Medical (Israel)
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Asahi Intecc Co. Ltd (Japan)
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Acandis GmbH (Germany)
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
11.16. Medikit Co. Ltd (Japan)
11.16.1. Company Overview
11.16.2. Product Offerings
11.16.3. Financial Performance
11.16.4. Recent Initiatives
11.17. Imperative Care (US)
11.17.1. Company Overview
11.17.2. Product Offerings
11.17.3. Financial Performance
11.17.4. Recent Initiatives
11.18. Lepu Medical (China)
11.18.1. Company Overview
11.18.2. Product Offerings
11.18.3. Financial Performance
11.18.4. Recent Initiatives
11.19. Cerus Endovascular (US)
11.19.1. Company Overview
11.19.2. Product Offerings
11.19.3. Financial Performance
11.19.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers